Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones

2025.11.28 22:23

I'm PortAI, I can summarize articles.

Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 2.86% to $11.54 on Friday, underperforming compared to competitors like Vanda Pharmaceuticals, Fortress Biotech, and Viking Therapeutics, which saw gains. The stock is 43.87% below its 52-week high of $20.56. Trading volume was significantly below the 50-day average. This occurred during a favorable trading session for the broader market, with the NASDAQ and Dow Jones indices both rising.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slipped 2.86% to $11.54 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.65% to 23,365.69 and the Dow Jones Industrial Average rising 0.61% to 47,716.42. Corbus Pharmaceuticals Holdings Inc. closed 43.87% short of its 52-week high of $20.56, which the company achieved on October 20th. The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. (VNDA) rose 1.13% to $5.36, Fortress Biotech Inc. (FBIO) rose 2.17% to $2.82, and Viking Therapeutics Inc. (VKTX) rose 1.49% to $36.81. Trading volume (199,008) remained 208,485 below its 50-day average volume of 407,493. Data source: Dow Jones Market Data, FactSet. Data compiled November 28, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-28-25 1723ET